NLRP6 and metabolic dysfunction-associated steatohepatitis: Upregulation of NLRP6 and IL-18 was also reported in adipose tissues obtained from NASH patients with portal fibrosis compared with that from control patients, suggesting a role of NLRP6 in liver disease (Henao-Mejia et al., 2012; Kanda et al., 2020).